• Capricor Therapeutics (NASDAQ:CAPR) Stock Rating Upgraded by Zacks Investment Research

    Capricor Therapeutics (NASDAQ:CAPR) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a note issued to …

    Read More
  • 0 0